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A  substance causing prolonged pressor effects in the rat has been demon- 
strated in crude protein-free extracts of hypertensive arterial blood (1).  This 
material formed picrates  which upon  hydrolysis were  further purified. Pre- 
liminary experiments indicated that a majority of the extracts of arterial blood 
taken from human hypertensive patients  were pressor,  while in only a  few 
samples of blood taken from normotensive patients was such activity demon- 
strated.  The present report  is  concerned with further demonstration of the 
presence of this vasoactive material and with the type of case in which it oc- 
curs (2-5), based upon experience with about 175 samples of blood. Subsequent 
reports will deal with methods of purification and analysis of chemical structure. 
The vasoactive substance was present in appreciable quantities in almost every 
case of hypertension having a  nephrogenic component, was found in smaller 
amounts in cases of "neurogenlc" and "endocrine" hypertension, and was us- 
ually absent in cases of "malignant"  hypertension.  The  finding  that  the 
"amine" level in hypertensive blood extracts is usually increased (1) has been 
confirmed. 
Because  the  substance  differs from other known pressor  agents and may 
represent a  new naturally occurring compound of great activity, it has been 
accorded a name--pherentasin  t (¢~po =  hold up or bear up;~vra~  =  pressure). 
Until chemical identification has been completed, pherentasin is defined as a 
substance  detected by assay in rats,  which induces a  prolonged pressor  re- 
sponse, contains an amine and a carbonyl group necessary for activity, is non- 
protein in nature, and can be procured from the arterial blood of many hyper- 
tensive patients at concentrations of 1 to 20  ~ per liter. 
* Work done under a grant-in-aid from the National Heart Institute, United States Pub- 
lic Health Service. 
:~ Present  address: Department of Biochemistry, Vanderbilt University School of Medi- 
vine, Nashville. 
Name suggested by Henry A, Schroeder, Jr. 
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Methods 
Rat Pressor Assay.--Two methods for assay of pherentasin were employed. The first was 
similar to that previously reported (1). Rats weighing 250 to 300 gin. were anesthetized with 
sodium pentobarbital (4.5  mg. per 100 gin. of body weight) and traeheotomy performed. A 
22 gauge needle connected to a Hamilton optical manometer was tied into a femoral artery; 
a  needle was tied into the opposite femoral vein for intravenous injection of materials to be 
tested. A  preliminary survey disclosed that rats made hypertensive by partial constriction 
of one renal artery were about twice as sensitive to the pressor material as normal rats; there- 
fore they were used in order to conserve material. 
Extracts were considered positive for pherentasin when the diastolic pressure of the rat 
was elevated at least 12 ram. Hg 10 minutes or more after the injection, a  figure chosen by 
comparison of the effects of control extracts of blood. Care was taken to insure that the rat 
did not become anoxic during the experiment. Many of the cruder extracts contained de- 
pressor substances which masked the activity; when the depressor material was removed by 
chemical purification, a pressor response appeared. The depressor responses did  not initiate 
compensatory rises in blood pressure, for the control extracts of blood uniformly contained 
more depressor material and were not pressor at any stage of purification. 
Rat Mesoappendix Assay.--The  second  method  was  that developed  by  Chambers and 
Zweifach utilizing the blood vessels of the rat's mesoappendix  (6).  2 Fasting rats weighing 
100  to  150  gin. were anesthetized with sodium pentobarbital and  tracheotomy performed. 
The abdomen was incised and the mesoappendix placed over a small horseshoe-shaped plastic 
structure. The vessels were viewed directly through a  microscope. Ringer's solution contain- 
ing 1  per cent gelatin at a  constant temperature of 38  ° slowly irrigated  the surface of the 
mesoappendix. Solutions of epinephrine in dilutions of 1:250,000 to  1:20,000,000  (4 to 0.5 
-y per ml.) were freshly prepared. To determine the sensitivity of the vessds to the minimal 
vasoconstrictor dose, application of four drops of each solution of epinephrine in increasing 
concentrations was repeated  until slowing of the blood stream through the met-arterioles 
and precapillaries for 15 to 30 seconds was observed. Care was taken not to exceed the mini- 
mal concentration which caused this reaction. After the level of sensitivity was determined 
by several topical applications of the same concentration of epinephrine, 0.1 ml. of the un- 
known solution (in this case an extract of blood) was injected into the vein of the tail. Changes 
in sensitivity of the vessels were then estimated by the application of solutions of epinephrine 
in gradually increasing or decreasing concentrations. When the vessels reacted to lower con- 
centrations of epinephrine than during the control period,  the unknown was considered to 
contain vasoexcitor material. When the concentration of epinephrine necessary to cause a 
vasoconstrictor response was greater than during the control, a  vasodepressor material was 
considered to have been injected intravenously. 
Applications of solutions of epinephrine were made at intervals of approximately 5 min- 
utes in order to measure the duration of the change in reactivity. The preparation was re- 
tested until the reactivity of the vessels had returned to or near to the control value. A change 
was considered to be significant when the effect of the intravenous injection of the unknown 
material lasted at least 15 minutes; usually it lasted 20 to 30 minutes. A response was also 
considered  significant when the concentration  of epineprine necessary to produce  transient 
vasoconstriction was either doubled or halved; in many cases changes were of much greater 
magnitude. In general, the sensitivity of the rat's mesoappendix to topically applied epineph- 
rine was found to be similar to that described by Zweifach (6), concentrations of 1:1,000,000 
to  1:4,000,000  causing slowing of the circulation through met-arterioles; the average con- 
We are indebted to Drs. Shorr and Zweifach for their aid and advice in  setting up  this 
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centration necessary was  approximately  1:2,000,000.  Each  extract was  tested  on at least 
two rats. 
Preparation of Extracts.--Arterial  blood was  taken directly through an 18 gauge needle 
and a short piece of rubber tubing into about 3 volumes of cold 95 per cent ethanol. Usually 
500 nil. of blood was obtained but in some cases this was impossible. Ethanol was added to 
a total of 11 volumes. The precipitated protein was removed by filtration; to the clear straw- 
colored solution was added 1 ml. of concentrated hydrochloric acid for each 200 ml. of orig- 
inal blood. The filtrate was evaporated almost to dryness in an atmosphere of nitrogen under 
a  partial vacuum, care being taken to maintain the temperature below 35°C. The crude ex- 
tracts were prepared as reported previously (1), placed in a deep freeze and kept in a  frozen 
state until assays were made. The extracts were further purified by the use of anionic and 
cationic exchange resins  (IR-100I-I and IR-4B)  and  by chloroform extraction; the details 
of the methods will be reported (7). The final solution containing the active agent was water- 
clear, the purest preparations containing approximately 10 to 20 3' of solids per liter of orig- 
inal blood.  The amount used  for pressor  assay was equivalent to 10 cc.  of original  blood 
which had been concentrated to 0.5 mi., dissolved in saline solution, and neutralized to pH 
7.4 by the addition of sodium bicarbonate. A]though the final extracts may not have been 
completely pure, 0.1 to 0.2 3" caused prolonged pressor responses in the rat, a range of dosage 
approximately equivalent to that of arterenol. About 0.01  to 0.02 3" produced vasoexcitor re- 
sponses in the mesoappendix test. 
Classification of Patients.--Patients  were  classified  according  to  a  method  previously 
reported  (8,  9). In brief, an attempt was made to place cases in one of four categories, de- 
pending upon the diseases  or  conditions.  For the purposes of  the present  study, modifica- 
tions in the classification were introduced. 
"Neurogenic hypertension" included those cases exhibiting a  fluctuating blood pressure, 
a  positive test to intradermal histamine (10)  with the development of the  "diencephalic" 
blush, a  low "floor'; after the intravenous injection of tetraethyl ammonium chloride (11), 
few symptoms, and a  rather benign course even though levels of blood pressure might be 
quite high. These patients showed little evidence of organic renal disease secondary to hyper- 
tension and the function of their kidneys was relatively normal. Sleep induced by sodium 
amytal was accompanied by a pronounced fall of blood pressure. There were 47 cases in this 
category. 
Patients with the "endocrine hypertensive syndrome" were characterized by the presence 
of obesity of the "central" type (trunk, thighs, upper arms), menstrual irregularities, other 
disturbances suggestive of endocrine disorders, and  the presence of a  low concentration of 
sodium in the sweat (12). Their blood pressures often became considerably reduced upon re- 
striction of dietary salt (13).  There were 12 patients in this category. 
Patients with renal hypertension included two types: first, those suffering from primary 
organic renal diseases at the onset of hypertension or during its course, which were subse- 
quently "masked;" second, patients believed to be suffering from secondary arteriolar nephro- 
sclerosis. Both types exhibited a relative lack of response to the intravenous injection of tetra- 
ethyl ammonium chloride or to sleep induced by sodium amytal. In general, diastolic pres- 
sures were "fixed" at relatively high levels; slight to moderate diminution of renal function, 
as measured by the ability of the kidneys to concentrate urine and by the urea clearance, 
was present; and a  more severe type of disease had developed. Nitrogen retention was not 
demonstrable in any. There were 35 cases of this type. 
Patients with malignant hypertension exhibited a  rapid downhill course, had diminished 
renal function, and hemorrhagic and exudative lesions in the ocular fundi with or without 
papilledema. When these lesions were present in the ocular fundi without retention of nitro- 
gen,  the patients were  considered  to exhibit early malignant hypertension. There were  17 
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Normotensive subjects were chosen from amongst ward patients who suffered from dis- 
eases not considered to be related to arterial hypertension. They furnished the control speci- 
mens. In every case their diastolic pressures were below 90 ram. Hg. There were 23 patients 
in the group. Five samples of venous blood obtained from the blood bank were also tested. 
Estimation of Amines.--"Amines" in the crude extracts of blood were measured by the 
method of Richter (14) ; the intensity of the yellow color developing on the addition of picric 
acid after extraction from alkaline solution into toluene was considered an estimate of the 
amine content.  The concentration was calculated in  terms of isoamylamine, as  different 
amines give different color-concentration curves (7). 
RESULTS 
Control Specimens:---Of  28 samples tested by rat pressor assay only 1 con- 
mined  pressor  material;  the  donor  suffered  from  infectious  mononucleosis 
(Table I). The mesoappendix test was employed on 19 samples; in only 2 was 
it positive, one being the patient with infectious mononucleosis, and the other 
an elderly woman convalescent from pneumonia.  None of the  5  samples  of 
venous blood obtained from the blood bank contained vasoactive substances 
as measured by either method. 
Specimens from Patients with Hypertension:--Only  10 of 47 extracts of blood 
taken from patients with neurogenic hypertension showed pressor activity in 
the  rat.  The mesoappendix test,  however, was positive for vasoexcitor sub- 
stances in 10 of 11 cases (Table II); 8 of these extracts were not pressor. 
Of 35  samples taken from patients with renal  hypertension,  33  gave pro- 
longed pressor responses in the rat. Ten extracts were also tested by the meso- 
appendix method; all contained vasoexcitor material. 
From cases of malignant hypertension  only 5  of  17  extracts were pressor 
in the rat; 2 of the patients yielding them suffered from cardiac insufficiency, 
and the other 3 were in initial phases of the malignant stage. No activity was 
exhibited by extracts of the blood of patients with malignant hypertension and 
uremia; none of the 3 samples tested by the mesoappendix method yielded a 
positive result. 
Three of 12 samples of blood from patients exhibiting the endocrine hyper- 
tensive syndrome contained pressor substance. Each of 3 others gave evidence 
of vasoexcitor substances in the mesoappendix test. 
Comparison of Results by the Two Assay Methods:--Correlation  of the pressor 
response with the reaction of the vessels of the rat's mesoappendix was good in 
one direction; i.e., a pressor response was always accompanied by a vasoexcitor 
response. This finding applied to all extracts, fractions, pooled samples, and 
the  more  highly  purified  material.  Positive  vasoexcitor responses,  however, 
were found not infrequently in the absence of pressor responses, both in single 
samples (12  cases) and in purified fractions obtained from pools. 
Validity of the Assay Method for Pherentasin Utilizing the Rat's Mesoappendix. 
--Assays for vasoactive material  in  hypertensive  blood,  by  the  method  of 
Chambers and Zweifach, were more definitive than was the pressor response HENRY  A. SCIIROEDER AND  NORMAN  S. OLSEN 
TABLE  I 
Pherentasin in Arterial Blood of Normotenslve Subjects 
549 
Case 
No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
"Amines' 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
Blood bank 
Blood bank 
Blood bank 
Blood bank 
Blood bank 
v/loo ~. 
43 
134 
9 
11 
0 
79 
34 
11 
17 
19 
119 
39 
17 
11 
Total positive .............  1/28 
Average. 37.0  33.9 
--  0 
--  C 
2/19 
Remarks 
Pneumonia, arteriosclerosis 
Infectious mononucleosis 
Infectious mononucleosis 
Postpneumonia 
Postappendectomy 
No disease 
R.H.D.* Aortic insufficiency 
Cellulitis 
Tularemia 
Coarctation of aorta 
Hydrarthrosis 
Psychoneurosis 
Cancer of lung 
Peptic ulcer 
R.H.D.* 
Syphilis 
Polycythemla 
Arthritis, arteriosclerosis 
Rheumatoid arthritis 
C.N.S. syphilis 
Coarctafion of aorta 
No disease 
R.H.D.* failure 
Fresh blood, shaken 1 hr. 
Syphilis, 4 days old 
30 days old 
30 days old 
Syphilis, 5 days old 
q- indicates that either pressor or vasoexcitor effects were obtained using the appropriate 
tests. 
-- indicates that no pressor or vasoexcitor effects were obtained. 
4- indicates that a  pressor response was obtained but that it was of short duration (5 
minutes or less). 
* Rheumatic heart disease. 
of the rat. The method was also much more sensitive but it was not specific. It 
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vessels to epinephrine. Potentiation of the vasoconstrictor action of epinephrine 
applied  topically  was  observed  after  the  intravenous  injection  of  ephedrine 
hydrochloride  (0.15 ? to  0.5 rag.), angiotonin  (0.05 ml.), and tyramine hydro- 
chloride  (0.15 ~, to 0.15 mg.), the effects lasting  15 minutes or longer. Depres- 
sion of the action of epinephrine was observed after the intravenous injection 
TABLE  II 
Pkerentasin in Hypertensive Blood 
Average blood 
pressure 
Positive 
assay of  "Amines  '~ 
pherentasin* 
Average  Type and severity 
No. of cases  cP  9  age  Rat  Meso-  ~  I  of hypertension 
ap-  "~ 
Systolic  Diastolic  pres-  pen-  ~  [ Average  sor  dlx  " 
test  test  ~l 
L 
yrs.  ram. ttg  ram. Hg  I "r/lO0 ml. 
9  3  6  38.7  165.5  105.0  1/9  2/2  6  ]  57.4  Mild neurogenic 
(30-51)  (180-140)  (118-90)  (122-0) 
I 
26  3  23  42.9  202.7  114.0  7/26  6/7  9  95.6  Moderate neurogenic 
(23-72)  (250-160)  (140-90)  (365-28) 
12  1  11  38.5  236.2  132.3  2/12  212  2  65.5  Severe neurogenic 
(36--48)  (300-204)  (150-110)  (120-9) 
12  0  12  42.7  199.3  118.3  3/12  3/3  1  5  Endocrine syndrome 
(32-52)  (250-160)  (140--94) 
35  21  14  45,2  206.2  125.9  33/35  10/10  18  71.4  Renal 
(23-58)  (260-164)  (160-110)  (120-26) 
17  8  9  44.4  237.4  144.2  5/17  0/3  4  53.3  Malignant 
(36-59)  (290-190)  (190-115)  ,(73-9) 
28  12  11  37.0  --  --  1/28  2/19  16  33,9  Normotension 
(15,-60)  [ (134q]) 
Total hyper-  t 
tension...  36  74  47/11G  23/27  40  71.0 
Figures  in parentheses  show ranges. 
* The first figure shows the number positive, the second the number tested. 
of adenosinetriphosphate  (0.05  to  1.0 rag.)  and  calcium pyridoxal  phosphate 
(0.01 to 1.0 rag.), the duration of depression lasting equally long with the two. 
Yeast  adenylic  acid  (0.5  mg.)  and  the acetate  and glucoside  of desoxycorti- 
costerone  (0.5 rag.)  caused no change in the response, although the latter was 
usually pressor for the rat. Over 50 tests with these agents were made and they 
suificed  to  indicate  that  the  method,  though  extremely  sensitive,  was  non- 
specific. Hence it was necessary  to control most observations on hypertensive 
extracts with comparable extracts of normotensive blood. 
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subjects.  Excluding cases in the malignant stages, hypertensive extracts, on 
the other hand, contained vasoexcitor material in every case tested but one. 
Pooled samples gave comparable results,  those from normotensive subjects 
containing no vasoexcitor material, whereas combined hypertensive extracts 
always  caused  potentiation  of  the  vasoconstrictor  action  of  epinephrine, 
whether pressor or not. 
Tests of purified fractions of the crude extracts of normotensive blood, ob- 
tained by the use of ion-exchange resins, indicated that the vasoexcitor sub- 
stance was not formed during the procedure.  All purified fractions of renal 
hypertensive blood, however, showed activity. The formation of a picrate of the 
vasoexcitor substance appeared to be a  useful method for its separation from 
depressor  substances  (7). 
The question naturally arises: Was pherentasin alone detected by the meso- 
appendix  method,  or  were  other  vasoexcit'or substances  present  in  certain 
instances? A  definite answer could not be obtained from a  large number of 
experiments performed.  Purified pherentasin,  which had  been recrystailized 
several times, was both pressor and vasoexcitor.  We were unable to separate 
pressor and vasoexcitor material in any one of numerous fractions and purified 
samples.  Chemical inactivation of the pressor  substance by several methods 
destroyed the vasoexcitor substance (7). The mesoappendix method was capable 
of detecting one-twentieth of the pressor dose of pherentasin; incomplete frac- 
tionation or dilution was the only procedure which retained the vasoexcitor 
factor while abolishing the pressor response. In two experiments with pooled 
samples which were not pressor but contained vasoexcitor material, further 
concentration caused the appearance of pressor effects; probably the material 
has been  too dilute to affect blood pressure  in  the standard concentrations 
employed for the pressor test. 
Miscellaneous Observations.--Thirty-six samples of blood were  taken from 
14 patients, and 2 to 5 samples from some of them were assayed months or 
years apart. The results were consistent in every case,  the presence or absence 
of the pressor material appearing to be constant in the same individual unless 
the nature of the disease itself had been altered by progression into more severe 
stages, or unless vigorous therapy had been instituted (Table III). 
During the course of investigation  (3 years)  the condition of a  number  of 
patients altered for the worse or was affected by various procedures.  These 
are informative. 
In a 38 year old woman  suffering  from pyelonephritis and severe hypertension  with a 
strong neurogenic component, 2 samples of blood taken 8 months apart were both positive 
for pressor substance. A sympathectomy was performed and a sample taken I year later  was 
negative. Two further  samples taken a year and 16 months later  were negative;  in the mean- 
time the pyelonephritis from which she suffered  had been controlled by nephrectomy of a 
diseased kidney. A 38 year old woman with severe hypertension and papiIIedema  but with- TABLE III 
Miscellaneous Observations 
Sex and  !  "~  Sub-  Type of  Date  i!  Blood  Diagnosis and remarkt  jeet  age  sample*  ¢~"~2  ~  ~  ~'~  .~=  pressure 
Consistency of results in repeated samples 
Sc. 
Mc. 
Mo. 
Ch. 
P1. 
Da. 
Or. 
Or. 
Cr. 
~r$.  ] 
o~49[ 
C  51 
43l 
9  32 
9  32 
o~43 
C  30 
37 
946 
mo.13'r.  I 
A  9/491 
A  4/501 
A  2/481 
A  3/501 
A  9/481 
A  4/491 
A  1/48[ 
A  10/491 
A  71481 
A  4/501 
A  12/471 
A  31481 
A  31481 
A  10/471 
A  2/48I 
A  1/471 
A  4/481 
A  9/491 
A  41501 
•]m•. 
O° 
+ 
+ 
+, 
+: 
i 
-! 
-! 
I 
=! 
ml 
--i 
+1++ 
+l  75 
+1  + 
+1  58 
+1  34 
-,+ 
~t 
+l 
+1 
170/108 
!170/110 
185/120 
246/130 
2Ao/140 
250/150 
150/100 
212/132 
225/130 
180/120 
200/130 
208/120! 
215/124! 
200/130 
210/160~ 
180/118! 
190/1101 
210/110] 
214/1301 
Moderate  neurogenic hypertension 
Moderate  neurogenic hypertension 
Moderate  renal  hypertension  with 
arteriosclerosis 
Severe renal hypertension 
Severe renal hypertension 
Endocrine hypertensive syndrome 
Endocrine hypertensive syndrome 
Hypo-ovarianism 
Hypo-ovarianism 
Severe renal hypertension 
Severe renal hypertension 
Severe renal hypertension 
Severe renal hypertension 
Early malignant hypertension 
Mild neurogenic hypertension 
Moderate neurogenic hypertension 
Moderate neurogenic hypertension 
Severe neurogenic hypertension 
Variations ~ ' results according to state of disease 
Hi. 
Ph. 
i 
9  38 
40 
1/47  +[. 
9/47  +l 
11/481  -, 
10/49  --, 
2/50  --, 
I  ' 
6/47  -- 
9/471 -,  + 
4/48} --, 
2/49  +1 
9/49  --,  -I- 
67  180/126 
43  210/120 
270/140 
210/120 
268/1441 
120  222/130 
99  220/130 
204/1201 
208/130! 
220/1301 
i 
Moderate  renal  and  neurogenie 
hypertension,  pyelonephrifis 
Severe renal and neurogenic hyper- 
tension,  pyelonephritis 
1 yr. after sympathectomy 
6 mos. after nephrectomy 
Neurogenic  hypertension--severe 
Neurogenic  hypertension--mod- 
erate 
Neurogenic hypertension--severe 
Neurogenic hypertension--severe 
Renal hypertension--moderate 
6 mos. after sympathectomy 
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Sex and  Sub-  Type of  ~  ~  Blood  ject  sample*  Date  ~  Diagnosis  and remarks  age  :~t~.~ ~  ~  pressure 
Variations  of results  accordin  to stage of dlsease-continued 
Wo. 
Ha. 
yt'$. 
23t 
24 
938 
Le.  942 
!  44 
A 
A 
A 
A 
A 
A 
A 
12/47  4-  9~ 
3/481  -- 
8/47t  +  +  12( 
9/471-  4-  36~ 
4/481  --  + 
8/471  - 
9/481  + 
ram, Hg 
188/114 
178/120 
188/120 
160/100 
218/150 
155/98 
17o/110 
Renal hypertension--severe 
1 mo. after sympathectomy 
Renal and neurogenic hypertension 
--severe 
After long rest in bed--improved 
8 mos. after sympathectomy 
Neurogenic hypertension--mild 
Neurogenic  hypertension--moder- 
ate 
Comparison  of results in arterial, venous, and renal venous samples 
9  49  Sp. 
Ca. 
Da. 
Ba. 
Ra. 
at. 
CI. 
Di. 
Cr. 
Wa. 
Ba. 
~49 
o~43 
o'44 
9  23 
c~ 38 
31 
32 
26 
37 
28 
A 
V 
A 
V 
A (3) 
VC 
RV 
A 
RV 
A (2) 
RV 
RV 
V 
V 
A 
RV 
A 
RV (2) 
+ 
-4- 
+ 
+ 
+ 
+ 
+ 
220/120 
9 
25o/14o 
75 208/120 
116 
73 228/138[ 
69 
14o/6o 
>160 
39 120/84 
17 120/80 
220/114 
170/115 
52t170/110 
71  180/120 
Endocrine hypertensive syndrome 
Endocrine hypertensive syndrome 
Renal hypertension--moderate 
Early malignant hypertension 
Coarctafion of aorta 
Mter 0.5 mg. epinephrine subcuta- 
neously 
Peptic ulcer 
Arthritis--blood  citrated  and 
shaken 
Renal hypertension 
Chronic glomerulonephritis 
Chronic glomerulonephritis 
Neurogenic  hypertension--moder- 
ate 
* A  =  arterial, V  -- venous, VC  -- vena cava, RV =  renal venous. 
A  -4- indicates that either pressor or vasoexeitor effects were  obtained using the appro- 
priate tests. 
A -- indicates that no pressor or vasoexcitor effects were obtained. 
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out other evidence of the malignant phase exhibited both pressor and vasoexcitor material 
in her blood. She was put to bed and given sedatives for several weeks. Her blood pressure 
dropped to slightly elevated levels, and the pressor but not the vasoexcitor material disap- 
peared. She was then subjected to sympathectomy; another sample contained only vaso- 
excitor material. A patient with neurogenic hypertension had 3 samples of blood containing 
no pressor substance; one  was  vasoexcitor. During  2  years' observation she  developed 
severe hypertension and showed evidence of slight diminution of renal function, with a fixed 
diastolic pressure. At that time her blood became positive. She was subjected to sympathec- 
tomy and after this only vasoexcitor material was found. In 3 other individuals the pressor 
material was no longer found in the blood after sympathectomy.  In these cases the absence 
of pressor material was not associated with normotensive levels. 
No  serious  attempt  was  made  to  determine  the  relative  concentration of 
vasoactive material in venous and arterial blood. However, 5 samples of normo- 
tensive venous blood, both freshly drawn and old, contained no active material. 
In 2 cases of endocrine hypertension venous samples were negative, but arterial 
samples were positive. In 2 cases of renal hypertension both venous and arterial 
samples were positive (Table III). 
In 6 instances right renal venous blood was obtained by intravenous catheter. 
In  2  normotensive  and  1 neurogenic hypertensive  case  the  blood  specimen 
exhibited no pressor activity. In one case of renal hypertension the blood was 
positive; in another suffering from glomerulonephritis no pressor activity was 
observed. The injection of epinephrine  appeared to cause liberation  of vaso- 
excitor material in 1 instance. In none of these 6 was the renal venous blood 
positive when blood obtained from other sources was negative. 
An attempt  was made in  7  instances  to  cause  the  liberation  of serotonin 
(15) from normal blood by drawing venous blood into citrate solution, by agi- 
taring citrated blood for 30 minutes, and by using blood 4 to 30 days old from 
the blood bank. No pressor or vasoexcitor material was detected in the extracts 
made from such samples. 
Amines__In general,  crude extracts  of hypertensive blood tended  to  con- 
tain more "amines" than did normotensive ones  (Fig.  1),  the average value 
being about twice as great (Table II), especially in samples from patients with 
renal hypertension. Arbitrary division of the cases shows that there were "high" 
values in 18 per cent of extracts from normotensive, 50 per cent of those from 
neurogenic  hypertensive,  and  83  per  cent  of  those  from  renal  hypertensive 
patients. 
The height of the amine picrate level was in general poorly correlated with 
the presence  or  absence  of pressor  or vasoexcitor material,  save  for certain 
exceptions. The highest normotensive amine picrate level was associated with 
both a positive pressor response and vasoexcitor material, as were some of the 
highest  amine  picrate  levels  in  the  neurogenic hypertensive group.  Patients 
with renal hypertension who were almost uniformly positive as regards pressor 
and vasoexcitor material had  in  general a  more consistently elevated  amine HENRY  A.  SCHROEDER  AND  NORMAN  S.  OLSEN  555 
picrate level. Purification of the extracts invariably decreased the level while 
increasing vasoactivity. 
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FIG.  1.  "Amine" level  of crude  extracts  of blood  expressed in  terms  of  isoamylamine. 
Each bar represents the measurement on blood from a single subject. The solid horizontal 
lines represent the arithmetical means for each group; the dotted line is an arbitrary division 
of cases below which all but 3 normotensive values lie. The two bars marked >160 represent 
extracts which contained so much material as to be cloudy. 
DISCUSSION 
The results of this study show that pherentasin, a pressor substance eliciting 
a prolonged response, can be obtained from the blood of cases exhibiting renal 
hypertension according to the definition here made. Patients with neurogenic 
hypertension and with the endocrine hypertensive syndrome have yielded less 
pherentasin.  The finding that  patients  with malignant  hypertension usually 
have little or none is surprising. The malignant stage of hypertension represents 
a  severe change in the character of the disease, involving necrotizing lesions 
in blood vessels, especially those of the kidney. 556  PI~SSOR  SUBSTANCES  IN  ARTERIAL  HYPERTENSION.  II 
We  have  been unable  to find pherentasin  in  cases  of chronic glomerulo- 
nephritis with uremia; without uremia it was present only in patients exhibiting 
predominately hypertensive disease. Hence it does not represent a product of 
renal retention, and indeed disappears  when retention of nitrogen develops. 
Perhaps other pressor systems, whose effector substances do not survive the 
procedure of extraction,  come into play when the  kidney becomes severely 
damaged. In spite of the fact that relatively large amounts of pherentasin ap- 
pear in the blood principally in cases of renal hypertension, there is no direct 
evidence from these data that it is a nephrogenic substance. 
Correlation of the presence or absence of pherentasin with the presence of 
hypertension was more definite in the present study than in the previous one 
(1). The relatively crude extracts of blood previously employed contained both 
pressor and depressor substances. When the depressor material was removed 
by the process of purification,  certain extracts of hypertensive blood which 
• had been toxic to rats were found to cause pressor and vasoexcitor effects. The 
presence of pherentasin therefore was  masked by depressor substances;  the 
earlier data were probably influenced by the crudeness of the preparations. 
More refined techniques and more sensitive methods of assay have shown this 
vasoactive material in extracts of the blood of almost every patient with hyper- 
tension without renal insufficiency. It was not found in cases of chronic glo- 
merulonephritis,  malignant  hypertension with  nitrogen  retention,  nor  in  1 
case of pheochromocytoma (I). Of patients with normal blood pressures,  I  of 
2 with infectious mononucleosis and 1 with arteriosclerosis, convalescent from 
pneumonia, showed vasoactive substance in the blood. There may have been 
small amounts in certain cases of congestive cardiac failure; too few patients 
have been studied for conclusions to be drawn. Pherentasin was not found in 
individuals exhibiting elevated systolic pressures accompanying aortic insu/fi- 
ciency, coarctation of aorta, and arteriosclerosis. The large quantities of blood 
necessary for assay made it impossible to study patients who were seriously fll 
or to whom the loss of blood would be deleterious. 
The pressor test in the rat has been found to be a fairly reliable method for 
the measurement of relatively large  quantities of pherentasin under certain 
conditions. A  calculation of the dosage obtained from the purest samples in- 
dicated that the method detected approximately 0.2 3'. The extracts of blood 
containing less than this amount served, in effect, as controls for those that 
contained more. Variability in the condition of the animals affected their re- 
sponses to the injections, but when at least 2 injections of an extract were made 
in each of 2 or more rats in good condition, the results were as consistent as 
expected in a biological method of assay. 
The mesoappendix test detected pherentasin  in quantities estimated from 
dry weights of approximately 0.01 3'. Extracts of normotensive blood treated in 
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About hal/of these not only contained no vasoexcitor material, but appeared 
to contain vasodepressor material, a finding not observed in extracts of hyper- 
tensive blood  The results do not indicate conclusively that pherentasin was 
the substance measured by this test.  When the pressor response was absent 
and the vasoexcitor response present, it is conceivable that the extract contained 
other substances which sensitized blood vessels to epinephrine. The results do 
show, however, that hypertension is usually accompanied by vasoexcitor sub- 
stances extractable from blood, that these cannot be separated from purified 
pherentasin, and that both pressor and vasoexcitor materials are inactivated 
by the same chemical procedures  (7).  Because the mesoappendix method is 
more sensitive in detecting small amounts of vasoactive substances than is the 
blood pressure of the animal, it is reasonable to assume that pherentasin is 
being measured by both types of test. 
The possibility that the pressor and vasoexcitor material is nicotine seems 
to have been excluded. Both smokers and non-smokers were equally distributed 
in the normotensive and hypertensive groups. The pressor response of nicotine 
is of relatively short duration and it is doubtful that nicotine would be carried 
through the procedure of extraction. Other exogenous pressor agents can like- 
wise be excluded from consideration. 
The procedure for extracting pherentasin was designed to protect amines 
from destruction by (a) precipitating the proteins in blood and so inactivating 
their enzymes, (b) preventing oxidation, (c) preventing distillation of volatile 
substances,  (d)  inhibiting hydrolysis by maintaining an acid medium and a 
cold environment, and  (e)  handling the material at all  times with extreme 
caution. After precipitation of proteins by alcohol and acidification, no drastic 
chemical or thermal changes were employed. It was obviously impossible to 
show, however, whether pherentasin was liberated from some parent substance 
by the procedure of extraction, or existed as such in the original blood. The fact 
that amines measured by the picrate method survived the extraction is some 
evidence for the possibility that pherentasin exists under natural conditions. 
Improved methods for its isolation from smaller quantities of blood may help 
to settle this question. 
An original assumption that the vasoactive material might be highly labile 
was supported by studies on the stability of the better purified solutions of 
pherentasin. When extracts were allowed to stand at room temperatures' for 
several hours or days they became inactive. Too much handling or too frequent 
thawing also reduced or abolished activity. Instability was especially evident 
in pooled extracts; it was necessary to exercise extreme caution to preserve the 
material in a frozen state until immediately before use. Disappearance of the 
pressor activity was accompanied frequently by the appearance of depressor 
activity, suggesting that  oxidation or  hydrolysis of pherentasin produces  a 
substance giving the opposite effect upon blood pressure. 558  PRESSOR  SUBSTANCES  IN  ARTERIAL  HYPERTENSION.  II 
The exact chemical nature of pherentasin is unknown. Chemical inactiva- 
tion and other studies have indicated that i,t contains a free amine and a car- 
bonyl group necessary for activity (7). Its pharmacological action differs from 
that of hypertensin, arterenol, and other known pressor agents. It may possibly 
represent the effector material of the sustained pressor substance obtained by 
Shipley, Helmer, and Kohlstaedt (I6), which is probably a protein closely asso- 
ciated with the renin fraction of renal tissue. Its relation to the vasoexcitor 
material (VEM) of Shorr et al. (17) is also undetermined, although it produces 
an identical response in the mesoappendix of the rat. VEM has not, however, 
been purified as yet. 
The picrate color measured in the extracts was not indicative of amines of 
high vasoactivity. The more potent pressor amines, especially those containing 
phenolic groups, were not measured by the method. Therefore, if significance 
is to be attached to the amine level in blood, it is only as an estimate of some 
metabolic fault in amino acid metabolism which may favor the production of 
other more potent vasoactive amines. 
It has not been determined that complete recovery of all the pherentasin the 
blood could yield was obtained by the methods used. Considering the lability 
of the substance itself, a  considerable amount may have been lost. The dry 
weight of the most purified active pool obtained showed concentrations of 10 
to 20 ~, per liter of original blood. When this concentration was induced in 
rat's blood by a  single injection of 0.2 "r (assuming a  blood volume of about 
15 ml.) diastolic pressure often rose 20 to 40 mm. Hg for 30 to 60 minutes. To 
reproduce  this response with arterenol  (nor-epinephrine)  a  continuous  slow 
infusionwhich maintained approximately the same concentration in blood would 
be required; arterenol is rapidly metabolized. Because pherentasin has a pressor 
activity by weight approximately equal to that of arterenol, but causes a much 
more prolonged effect, it is doubtful that concentrations much greater than 
those  recovered  existed  in  the  original blood  of patients.  The  recovery  of 
pherentasin from human hypertensive blood suggests that it bears a causal or 
mediating relationship to hypertension. Further studies on its chemical nature 
are in progress. 
S~RY  AND CONCLUSIONS 
Pherentasin, a highly active pressor substance producing a prolonged effect in 
the rat, has been obtained in a  fairly pure form from the arterial blood of 
patients with hypertension. Its presence has been demonstrated by two biolog- 
ical methods. It was rarely found in normotensive blood. The blood of patients 
with renal  or  nephrogenic hypertension, either  primary  or  secondary,  con- 
sistently yielded this material. The blood of patients exhibiting neurogenic 
hypertension and the endocrine hypertensive syndrome had smaller amounts HENRY  A. SCHROEDER  AND  NORMAN  S. OLSEN  559 
of it. Little or none was found in malignant hypertension. Perhaps pherentasin 
has a causal relation to the existence of arterial hypertension. 
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